PEDIATRICS Vol. 97 No. 4 April 1996, pp. 443-448
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Langnas, A. N.
Right arrow Articles by Vanderhoof, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Langnas, A. N.
Right arrow Articles by Vanderhoof, J. A.

Preliminary Experience With Intestinal Transplantation in Infants and Children

Alan N. Langnas DO1, B. W. Shaw Jr MD1, Dean L. Antonson MD2, Stuart S. Kaufman MD2, David R. Mack MD2, Thomas G. Heffron MD1, Ira J. Fox MD1, and Jon A. Vanderhoof MD2

1 Department of Surgery, University of Nebraska Medical Center, Omaha
2 Department of Pediatrics, University of Nebraska Medical Center, Omaha

Objective. This report discusses the preliminary experience with intestinal transplantation in children at the University of Nebraska Medical Center.

Patients. During the past 4 years, 16 intestinal transplants have been performed in infants and children. Thirteen have been combined liver and bowel transplants, and the remainder were isolated intestinal transplants. Nearly half of the patients were younger than 1 year of age at the time of surgery, and the vast majority were younger than 5 years of age. All but one had short bowel syndrome.

Results. The 1-year actuarial patient and graft survival rates for recipients of liver and small bowel transplants were 76% and 61%, respectively. Eight of 13 patients who received liver and small bowel transplants remain alive at the time of this writing, with a mean length of follow-up of 263 (range, 7 to 1223) days. Six patients are currently free of total parenteral nutrition. All three patients receiving isolated intestinal transplants are alive and free of parenteral nutrition. The mean length of follow-up is 384 (range, 330 to 450) days. Major complications have included severe infections and rejection. Lymphoproliferative disease, graft-versus-host disease, and chylous ascites have not been major problems.

Conclusions. Although intestinal transplantation is in its infancy, these preliminary results suggest combined liver and bowel transplants and isolated intestinal transplantation may be viable options for some patients with intestinal failure caused by short bowel syndrome or other gastrointestinal disease in whom long-term total parenteral nutrition is not an attractive option.

Submitted on February 10, 1995
Accepted on April 17, 1995




This article has been cited by other articles:


Home page
 J. Immunol.Home page
Z. Zhang, L. Kaptanoglu, W. Haddad, D. Ivancic, Z. Alnadjim, S. Hurst, D. Tishler, A. D. Luster, T. A. Barrett, and J. Fryer
Donor T Cell Activation Initiates Small Bowel Allograft Rejection Through an IFN-{gamma}-Inducible Protein-10-Dependent Mechanism
J. Immunol., April 1, 2002; 168(7): 3205 - 3212.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
D. G. Farmer, S. V. McDiarmid, H. Yersiz, G. Cortina, F. Amersi, J. Vargas, G. Gershman, M. Ament, and R. W. Busuttil
Outcome After Intestinal Transplantation: Results From One Center's 9-Year Experience
Arch Surg, September 1, 2001; 136(9): 1027 - 1032.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
E. Haddad, S. Paczesny, V. Leblond, J.-M. Seigneurin, M. Stern, A. Achkar, M. Bauwens, V. Delwail, D. Debray, C. Duvoux, et al.
Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial
Blood, March 15, 2001; 97(6): 1590 - 1597.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
S Sarnacki, F Auber, C Cretolle, C Camby, M Cavazzana-Calvo, W Muller, N Wagner, N Brousse, Y Revillon, A Fischer, et al.
Blockade of the integrin alpha Lbeta 2 but not of integrins alpha 4 and/or beta 7 significantly prolongs intestinal allograft survival in mice
Gut, July 1, 2000; 47(1): 97 - 104.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
G. Vennarecci, T. Kato, E. P. Misiakos, A. B. Neto, R. Verzaro, A. Pinna, J. Nery, F. Khan, J. F. Thompson, and A. G. Tzakis
Intestinal Transplantation for Short Gut Syndrome Attributable to Necrotizing Enterocolitis
Pediatrics, February 1, 2000; 105(2): 25e - 25.
[Abstract] [Full Text]

Home page
 PediatricsHome page
T. R. Cooper, J. A. Garcia-Prats, and B. A. Brody
Managing Disagreements in the Management of Short Bowel and Hypoplastic Left Heart Syndrome
Pediatrics, October 1, 1999; 104(4): 48e - 48.
[Abstract] [Full Text]

Home page
 BloodHome page
M. Benkerrou, J.-P. Jais, V. Leblond, A. Durandy, L. Sutton, P. Bordigoni, J. L. Garnier, J. Le Bidois, F. Le Deist, S. Blanche, et al.
Anti-B-Cell Monoclonal Antibody Treatment of Severe Posttransplant B-Lymphoproliferative Disorder: Prognostic Factors and Long-Term Outcome
Blood, November 1, 1998; 92(9): 3137 - 3147.
[Abstract] [Full Text] [PDF]

Home page
 JWatch GeneralHome page
INTESTINAL TRANSPLANTATION IN CHILDREN
Journal Watch (General), April 23, 1996; 1996(423): 5 - 5.
[Full Text]